SCHEMBL1345684

SCHEMBL1345684

NC(=O)c1cccc(-c2ccc(CNCCC3CCC(=O)CC3)cc2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 2/20 0.46
OPRD1 P41143 2/20 0.46
OPRK1 P41145 2/20 0.46
CNR1 P21554 1/20 0.45
NR3C2 P08235 1/20 0.44
PARP1 P09874 1/20 0.42
PARP15 Q460N3 1/20 0.42
PARP10 Q53GL7 1/20 0.42
CTSK P43235 1/20 0.40
CTSC P53634 1/20 0.40
HDAC1 Q13547 2/20 0.40
TDP2 O95551 1/20 0.40
CSF1R P07333 1/20 0.40
FLT1 P17948 1/20 0.40
FLT3 P36888 1/20 0.40
ERN1 O75460 1/20 0.39
FAAH O00519 2/20 0.39
EPHX2 P34913 2/20 0.38
TRPA1 O75762 1/20 0.38
FAAH2 Q6GMR7 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1347674 0.90 OPRM1 (0.48) OPRM1OPRD1OPRK1CNR1NR3C2
SCHEMBL1348267 0.89 MEN1 (0.48) OPRM1OPRD1OPRK1CNR1NR3C2
SCHEMBL1347790 0.85 CNR1 (0.43) OPRM1OPRD1OPRK1CNR1NR3C2
Trifluoroacetic Acid SCHEMBL3343134 0.83 HTR5A (0.47) OPRM1OPRD1OPRK1CNR1NR3C2
SCHEMBL1347716 0.83 SIGMAR1 (0.50) OPRM1OPRD1OPRK1CNR1NR3C2
SCHEMBL1346045 0.83 OPRM1 (0.45) OPRM1OPRD1OPRK1CNR1NR3C2
SCHEMBL1787140 0.78 MEN1 (0.57) OPRM1OPRD1OPRK1CNR1NR3C2
SCHEMBL1345988 0.78 MEN1 (0.57) OPRM1OPRD1OPRK1CNR1NR3C2
SCHEMBL13929391 0.77 CNR1 (0.42) OPRM1OPRD1OPRK1CNR1NR3C2
SCHEMBL1347426 0.77 OPRM1 (0.52) OPRM1OPRD1OPRK1CNR1NR3C2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8063247-B2 Bicyclic aryl and heteroaryl receptor modulators PROSIDION LIMITED (GB) 2011-11-22 US disclosed
US-20100267780-A1 BICYCLIC ARYL AND HETEROARYL RECEPTOR MODULATORS PROSIDION LIMITED (GB) 2010-10-21 US disclosed
EP-2197835-A1 BICYCLIC ARYL AND HETEROARYL RECEPTOR MODULATORS Prosidion Limited (GB) 2010-06-23 EP disclosed
WO-2009030962-A1 BICYCLIC ARYL AND HETEROARYL RECEPTOR MODULATORS PROSIDION LIMITED (GB) 2009-03-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100267780-A1 BICYCLIC ARYL AND HETEROARYL RECEPTOR MODULATORS OPRM1, OPRL1, OPRD1 OPRM1 1/4885OPRD1 3/4885OPRK1 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.